BioNTech CEO Ugur Sahin: "Our vaccine will likely work for mutated coronavirus variants"

×

[TRT Haber] Sağlık Bakanlığı, BioNTech aşısının uygulanmasına yönelik kılavuz yayımladı. Kılavuza göre, ilk doz sonrası ciddi alerjik reaksiyon gösterenlere ikinci doz aşı ... BioNTech aşı kılavuzu yayımlandı ... Daha fazla göster

[Diken] Sağlık Bakanlığı Türkiye'de uygulanmaya başlayan BioNTech/Pfizer aşısının kullanımıyla ilgili kurallar rehberini yayınladı. Fotoğraf: Reuters. Buna göre aşının ... BioNTech aşısı kimlere yapılamaz, nelere dikkat edilmeli? - Diken ... Daha fazla göster

[Sözcü] Vatandaşlardan Biontech aşısına yoğun ilgi Sivas'ta bugün itibariyle vatandaşlara Biontech aşısı da uygulanmaya başladı. Aşıya gelenlerin daha çok Biontech'i ... Vatandaşlardan Biontech aşısına yoğun ilgi ... Daha fazla göster

[NTV] Türkiye'de Türk bilim insanları Özlem Türeci ve Uğur Şahin tarafından geliştirilen Pfizer-Biontech aşılarının uygulanmasına bugün başlandı.Eksi 70 derecede ... Biontech aşısının yolculuğu (Depodan hastaneye) ... Daha fazla göster

Etiketler

Benzer Resimler

Inside the hunt for a Covid-19 vaccine: how BioNTech made the breakthrough

Inside the hunt for a Covid-19 vaccine: how BioNTech made the breakthrough

2048 × 1152
Covid-19-Impfstoff: Biontech und Pfizer beantragen bedingte Zulassung in d  | PZ – Pharmazeutische Zeitung

Covid-19-Impfstoff: Biontech und Pfizer beantragen bedingte Zulassung in d | PZ – Pharmazeutische Zeitung

1128 × 751
How Pfizer Partner BioNTech Became a Leader in Coronavirus Vaccine Race -  WSJ

How Pfizer Partner BioNTech Became a Leader in Coronavirus Vaccine Race - WSJ

1280 × 1280
BioNTech CEO on vaccine progress with Pfizer

BioNTech CEO on vaccine progress with Pfizer

Biontech-Gründer Uğur Şahin im Interview zu seinem Corona-Impfstoff

Biontech-Gründer Uğur Şahin im Interview zu seinem Corona-Impfstoff

BioNTech CEO Ugur Sahin:

BioNTech CEO Ugur Sahin: "Our vaccine will likely work for mutated coronavirus variants"

Biontech Aşısı mı Sinovac Aşısı mı Güvenli! İşte Detaylar

Biontech Aşısı mı Sinovac Aşısı mı Güvenli! İşte Detaylar

STEINMEIER WÜRDIGT BIONTECH-GRÜNDER: Türeci und Sahin leisteten

STEINMEIER WÜRDIGT BIONTECH-GRÜNDER: Türeci und Sahin leisteten "Dienst an der Menschheit"

Live-Interview mit Biontech-Chef Prof. Ugur Sahin zu Corona-Impfstoff

Live-Interview mit Biontech-Chef Prof. Ugur Sahin zu Corona-Impfstoff

Corona-Impfstoff: Das sind die Nebenwirkungen laut Biontech-Studie

Corona-Impfstoff: Das sind die Nebenwirkungen laut Biontech-Studie

“Even though this new variant has multiple mutations, only one percent of this protein is changed. And that means 99 percent are still the same,” Biontech CEO Ugur Sahin told DW. He said his company needed two weeks to determine whether the vaccine can inactivate it.
“Scientifically the likelihood is high” that the vaccine developed by Biontech and Pfizer will work against the new variant, Sahin said, adding that “I am confident that if there is a need for a change, that the technology that we are using, the messenger RNA technology, could deliver the change.” In case the current vaccine did not work, “we can produce a new vaccine in about six weeks,” Sahin said, adding that the production would be followed by a lengthy trial and approval process. “We have to discuss with the authorities whether they would accept such a change of the vaccine. This is a scientific and medical discussion.”
Biontech has announced deliveries to EU member states before Christmas and expects to send out 12.5 million doses before the end of the year. “We are really interested in making our vaccines globally available. And we are working with authorities worldwide to ensure that they can get access to our vaccine,” Sahin said.

Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1

For more news go to: http://www.dw.com/en/
Follow DW on social media:
►Facebook: https://www.facebook.com/deutschewellenews/
►Twitter: https://twitter.com/dwnews
►Instagram: https://www.instagram.com/dwnews
Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/channel/deutschewelle
#BioNTech #UgurSahin #Vaccine
Inside the hunt for a Covid-19 vaccine: how BioNTech made the breakthrough. Covid-19-Impfstoff: Biontech und Pfizer beantragen bedingte Zulassung in d | PZ – Pharmazeutische Zeitung. How Pfizer Partner BioNTech Became a Leader in Coronavirus Vaccine Race - WSJ. BioNTech CEO on vaccine progress with Pfizer. Biontech-Gründer Uğur Şahin im Interview zu seinem Corona-Impfstoff. BioNTech CEO Ugur Sahin: "Our vaccine will likely work for mutated coronavirus variants". Biontech Aşısı mı Sinovac Aşısı mı Güvenli! İşte Detaylar. STEINMEIER WÜRDIGT BIONTECH-GRÜNDER: Türeci und Sahin leisteten "Dienst an der Menschheit". Live-Interview mit Biontech-Chef Prof. Ugur Sahin zu Corona-Impfstoff. Corona-Impfstoff: Das sind die Nebenwirkungen laut Biontech-Studie.